ResearcherShanghai Jiao Tong UniversityActive in the last 2 years
Yan-Zhi Gai
Matched on ORCID iD 0000-0002-7440-8389. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 21
2022: 2 papers · 2023: 1 paper · 2024: 4 papers
Papers 7
- Retraction Note: Vacuolar protein sorting 35 (VPS35) acts as a tumor promoter via facilitating cell cycle progression in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s10142-024-01383-2↗
- Progesterone receptor potentiates macropinocytosis through CDC42 in pancreatic ductal adenocarcinoma. First author DOI 10.1038/s41389-024-00512-7↗
- Prolactin receptor potentiates chemotherapy through miRNAs-induced G6PD/TKT inhibition in pancreatic cancer. Co-author DOI 10.1096/fj.202302287rr↗
- A Nutrient-Deficient Microenvironment Facilitates Ferroptosis Resistance via the FAM60A-PPAR Axis in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.34133/research.0300↗
- Vacuolar protein sorting 35 (VPS35) acts as a tumor promoter via facilitating cell cycle progression in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s10142-023-01020-4↗
- A low amino acid environment promotes cell macropinocytosis through the YY1-FGD6 axis in Ras-mutant pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41388-021-02159-9↗
- Diet-Induced Obesity Promotes Liver Metastasis of Pancreatic Ductal Adenocarcinoma via CX3CL1/CX3CR1 Axis. Co-author DOI 10.1155/2022/5665964↗
Closest collaborators
The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hui Nie · 7 shared papers, 2022–2024 · strength 1.30
- Paper Prolactin receptor potentiates chemotherapy through miRNAs-induced G6PD/TKT inhibition in pancreatic cancer. DOI 10.1096/fj.202302287rr↗
- Paper A Nutrient-Deficient Microenvironment Facilitates Ferroptosis Resistance via the FAM60A-PPAR Axis in Pancreatic Ductal … DOI 10.34133/research.0300↗
- Paper Progesterone receptor potentiates macropinocytosis through CDC42 in pancreatic ductal adenocarcinoma. DOI 10.1038/s41389-024-00512-7↗
- Yingna Liao · 3 shared papers, 2023–2024 · strength 0.58
- Paper Prolactin receptor potentiates chemotherapy through miRNAs-induced G6PD/TKT inhibition in pancreatic cancer. DOI 10.1096/fj.202302287rr↗
- Paper Retraction Note: Vacuolar protein sorting 35 (VPS35) acts as a tumor promoter via facilitating cell cycle progression i… DOI 10.1007/s10142-024-01383-2↗
- Paper Vacuolar protein sorting 35 (VPS35) acts as a tumor promoter via facilitating cell cycle progression in pancreatic duct… DOI 10.1007/s10142-023-01020-4↗
- Xueli Zhang · 3 shared papers, 2022–2024 · strength 0.46
- Paper Retraction Note: Vacuolar protein sorting 35 (VPS35) acts as a tumor promoter via facilitating cell cycle progression i… DOI 10.1007/s10142-024-01383-2↗
- Paper Vacuolar protein sorting 35 (VPS35) acts as a tumor promoter via facilitating cell cycle progression in pancreatic duct… DOI 10.1007/s10142-023-01020-4↗
- Paper A low amino acid environment promotes cell macropinocytosis through the YY1-FGD6 axis in Ras-mutant pancreatic ductal a… DOI 10.1038/s41388-021-02159-9↗
- Xiaomei Yang · 3 shared papers, 2022–2024 · strength 0.46
- Paper Retraction Note: Vacuolar protein sorting 35 (VPS35) acts as a tumor promoter via facilitating cell cycle progression i… DOI 10.1007/s10142-024-01383-2↗
- Paper Vacuolar protein sorting 35 (VPS35) acts as a tumor promoter via facilitating cell cycle progression in pancreatic duct… DOI 10.1007/s10142-023-01020-4↗
- Paper A low amino acid environment promotes cell macropinocytosis through the YY1-FGD6 axis in Ras-mutant pancreatic ductal a… DOI 10.1038/s41388-021-02159-9↗
- Ying-Na Liao · 2 shared papers, 2024 · strength 0.45
- Shu‐Heng Jiang · 2 shared papers, 2023–2024 · strength 0.34
- Paper Retraction Note: Vacuolar protein sorting 35 (VPS35) acts as a tumor promoter via facilitating cell cycle progression i… DOI 10.1007/s10142-024-01383-2↗
- Paper Vacuolar protein sorting 35 (VPS35) acts as a tumor promoter via facilitating cell cycle progression in pancreatic duct… DOI 10.1007/s10142-023-01020-4↗
- Yifan Zhang · 2 shared papers, 2022–2024 · strength 0.34
- Hong Pan · 1 shared paper, 2024 · strength 0.23
- Yan‐Miao Huo · 1 shared paper, 2024 · strength 0.23
- Hui Li · 1 shared paper, 2024 · strength 0.18
- Hui Li · 1 shared paper, 2023 · strength 0.16
- Shan Zhang · 1 shared paper, 2023 · strength 0.16
- Dong‐Xue Li · 1 shared paper, 2022 · strength 0.16
- Yue Sun · 1 shared paper, 2022 · strength 0.16
- Zhigang Zhang · 1 shared paper, 2022 · strength 0.12
- Dongxue Li · 1 shared paper, 2022 · strength 0.12
- Qing Li · 1 shared paper, 2022 · strength 0.12
- Yongwei Sun · 1 shared paper, 2022 · strength 0.12
- Li-Peng Hu · 1 shared paper, 2022 · strength 0.12
- Linli Yao · 1 shared paper, 2022 · strength 0.12
- Dejun Liu · 1 shared paper, 2022 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.